医疗服务企业ComplexCare获华平4000万美元投资

2014-01-13 佚名 生物探索

专业为医疗保险计划提供风险评估和护理管理服务的美国ComplexCare Solutions公司("ComplexCare")1月9日宣布,私募股权投资机构美国华平投资集团("华平")已向公司投资4000万美元,以支持其未来业务发展。ComplexCare的管理层将继续持有公司大量股权。 ComplexCare公司成立于2010年,目前已迅速成长为一家领先的医疗健康服务企业。公司通过一支富有经验

专业为医疗保险计划提供风险评估和护理管理服务的美国ComplexCare Solutions公司("ComplexCare")1月9日宣布,私募股权投资机构美国华平投资集团("华平")已向公司投资4000万美元,以支持其未来业务发展。ComplexCare的管理层将继续持有公司大量股权。

ComplexCare公司成立于2010年,目前已迅速成长为一家领先的医疗健康服务企业。公司通过一支富有经验的跨科室的护理和管理团队,提供家庭健康评估和护理管理服务,而美国该类服务外包现有市场总量为10亿美元。随着美国健保优惠(Medicare Advantage), 长期护理管理计划(Managed Long-term Care),医疗援助制度(Managed Medicaid)和其他保险计划对高危人群加强提供护理的需求不断增长,外包服务的市场将在未来五年翻番。

ComplexCare公司董事长约翰·兰达佐(John Randazzo)表示:"华平的投资证明了我们在健康风险评估和护理管理服务市场上的领导地位。"公司首席执行官马克·布拉克伯恩(Mark Blackburn)表示:"和华平携手,可以使公司更好的利用华平的经验、专长和资金支持,继续专注业务拓展,抓住新市场机会,发挥我们为支付方、护理机构和患者护理服务提供的创新型解决方案和经验优势,从而满足医疗健康市场不断发展变化的需求,加快实现公司长期业务规划。"

华平董事总经理、全球医疗投资负责人贝斯·韦瑟曼(Bess Weatherman)表示:"ComplexCare的强劲的核心业务能力,以及美国健保优惠计划和医疗援助计划的受益人更多的转向商业保险计划,我们相信公司未来将更加成功。"

关于ComplexCare Solutions公司

ComplexCare Solutions是一家总部位于美国纽约的健康服务公司,在纽约、罗切斯特、阿尔巴尼、纳什维尔和圣胡安市都设有服务中心。公司专注于对健保优惠、长期护理管理计划、医疗援助计划、特殊需求计划以及商业保险的会员提供面对面的健康服务。ComplexCare的主要服务内容是为复杂病症、虚弱、老年和有特殊需求的患者以及以上双重需求的患者提供整合服务。

关于美国华平投资集团

美国华平投资集团是领先的国际私募股权投资机构,专注于成长型投资。华平旗下管理350亿美元的资产,在全球各地投资于多个行业,目前在125家公司持有股权。华平是企业家和管理团队的伙伴,致力于帮助企业长期发展。华平成立于1966年,迄今为止已募集了13期私募基金,共在35个国家投资了675家公司,总投资额逾450亿美元。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1773155, encodeId=ece81e7315517, content=<a href='/topic/show?id=5298121e46e' target=_blank style='color:#2F92EE;'>#MPL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12174, encryptionId=5298121e46e, topicName=MPL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10e638510530, createdName=xuyong536, createdTime=Thu Jun 19 09:14:00 CST 2014, time=2014-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783601, encodeId=7a6a1e8360138, content=<a href='/topic/show?id=914c503437' target=_blank style='color:#2F92EE;'>#complex#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5034, encryptionId=914c503437, topicName=complex)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sat Apr 12 16:14:00 CST 2014, time=2014-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1303419, encodeId=d4c61303419cf, content=<a href='/topic/show?id=90fa35013c4' target=_blank style='color:#2F92EE;'>#医疗服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35013, encryptionId=90fa35013c4, topicName=医疗服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Wed Jan 15 01:14:00 CST 2014, time=2014-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456013, encodeId=ab28145601342, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Wed Jan 15 01:14:00 CST 2014, time=2014-01-15, status=1, ipAttribution=)]
    2014-06-19 xuyong536
  2. [GetPortalCommentsPageByObjectIdResponse(id=1773155, encodeId=ece81e7315517, content=<a href='/topic/show?id=5298121e46e' target=_blank style='color:#2F92EE;'>#MPL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12174, encryptionId=5298121e46e, topicName=MPL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10e638510530, createdName=xuyong536, createdTime=Thu Jun 19 09:14:00 CST 2014, time=2014-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783601, encodeId=7a6a1e8360138, content=<a href='/topic/show?id=914c503437' target=_blank style='color:#2F92EE;'>#complex#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5034, encryptionId=914c503437, topicName=complex)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sat Apr 12 16:14:00 CST 2014, time=2014-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1303419, encodeId=d4c61303419cf, content=<a href='/topic/show?id=90fa35013c4' target=_blank style='color:#2F92EE;'>#医疗服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35013, encryptionId=90fa35013c4, topicName=医疗服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Wed Jan 15 01:14:00 CST 2014, time=2014-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456013, encodeId=ab28145601342, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Wed Jan 15 01:14:00 CST 2014, time=2014-01-15, status=1, ipAttribution=)]
    2014-04-12 tidiq
  3. [GetPortalCommentsPageByObjectIdResponse(id=1773155, encodeId=ece81e7315517, content=<a href='/topic/show?id=5298121e46e' target=_blank style='color:#2F92EE;'>#MPL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12174, encryptionId=5298121e46e, topicName=MPL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10e638510530, createdName=xuyong536, createdTime=Thu Jun 19 09:14:00 CST 2014, time=2014-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783601, encodeId=7a6a1e8360138, content=<a href='/topic/show?id=914c503437' target=_blank style='color:#2F92EE;'>#complex#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5034, encryptionId=914c503437, topicName=complex)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sat Apr 12 16:14:00 CST 2014, time=2014-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1303419, encodeId=d4c61303419cf, content=<a href='/topic/show?id=90fa35013c4' target=_blank style='color:#2F92EE;'>#医疗服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35013, encryptionId=90fa35013c4, topicName=医疗服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Wed Jan 15 01:14:00 CST 2014, time=2014-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456013, encodeId=ab28145601342, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Wed Jan 15 01:14:00 CST 2014, time=2014-01-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1773155, encodeId=ece81e7315517, content=<a href='/topic/show?id=5298121e46e' target=_blank style='color:#2F92EE;'>#MPL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12174, encryptionId=5298121e46e, topicName=MPL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10e638510530, createdName=xuyong536, createdTime=Thu Jun 19 09:14:00 CST 2014, time=2014-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783601, encodeId=7a6a1e8360138, content=<a href='/topic/show?id=914c503437' target=_blank style='color:#2F92EE;'>#complex#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5034, encryptionId=914c503437, topicName=complex)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sat Apr 12 16:14:00 CST 2014, time=2014-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1303419, encodeId=d4c61303419cf, content=<a href='/topic/show?id=90fa35013c4' target=_blank style='color:#2F92EE;'>#医疗服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35013, encryptionId=90fa35013c4, topicName=医疗服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Wed Jan 15 01:14:00 CST 2014, time=2014-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456013, encodeId=ab28145601342, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Wed Jan 15 01:14:00 CST 2014, time=2014-01-15, status=1, ipAttribution=)]
    2014-01-15 hyf030